13.05.2024 11:19:54
|
Amazon, Microsoft, Pfizer To Invest Billions In French Projects
(RTTNews) - Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said.
French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment, as part of the Government's efforts to re-industrialize the country.
In a statement, Amazon said it plans to invest more than 1.2 billion euros or $1.3 billion in its French operations, which is expected to create more than 3,000 permanent jobs in the country.
Further, tech and software giant Microsoft plans to invest 4 billion euros or $4.3 billion in France, mainly to focus on the artificial intelligence or AI sector.
Healthcare companies Pfizer and AstraZeneca also announced investments worth a total of nearly $1 billion. Other companies, including GSK and Accenture are expected to announce investments as part of the event.
GSK would announce new investments while Accenture would announce plans to set up new jobs in the artificial intelligence sector.
Morgan Stanley would open a new office in the country, its new European campus, which is expected to create 100 more jobs in Paris.
French Finance Minister Bruno Le Maire reportedly will also host meetings with the CEOs of JPMorgan, Goldman Sachs, Morgan Stanley and Bank of America, among others.
At last year's summit, around 13 billion euros worth of foreign investments were announced by the country.
Under Amazon's planned investment, Amazon Web Services is expected to increase cloud infrastructure in the Paris area to support France's generative AI opportunity, and logistics infrastructure to increase speed of delivery and reduce carbon emissions. Frederic Duval, country manager at Amazon France said the latest jobs are in addition to the 2,000 jobs the firm announced for 2024. Since 2010, Amazon has invested more than 20 billion euros in its French operations.
Microsoft's planned 4 billion euros or $4.3 billion investment in France would mainly focus on the artificial intelligence or AI sector. According to its vice chair and president Brad Smith, the company would set up a data centre in the French city of Mulhouse.
Further, drug major Pfizer would invest 500 million euros or $538.5 million in France to build up its research and development work, while AstraZeneca would invest $388 million for its site at Dunkirk.
Le Maire reportedly said, "New industries and the new economy need massive amounts of capital. We urgently need to take concrete steps to get the capital markets union going. … Europe needs money. If not, it will continue to lose out in terms of productivity to the United States and China."
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AstraZeneca PLC (spons. ADRs)mehr Nachrichten
18.12.24 |
Anleger in New York halten sich zurück: NASDAQ 100 verbucht nachmittags Abschläge (finanzen.at) | |
04.12.24 |
NASDAQ 100 aktuell: NASDAQ 100 beginnt Mittwochssitzung im Plus (finanzen.at) | |
03.12.24 |
NASDAQ 100 aktuell: NASDAQ 100 liegt letztendlich im Plus (finanzen.at) | |
03.12.24 |
Starker Wochentag in New York: NASDAQ 100 nachmittags mit Kursplus (finanzen.at) | |
03.12.24 |
NASDAQ 100 aktuell: NASDAQ 100 am Mittag in Rot (finanzen.at) | |
03.12.24 |
NASDAQ 100 aktuell: NASDAQ 100 beginnt die Dienstagssitzung in der Verlustzone (finanzen.at) | |
12.11.24 |
AstraZeneca-Aktie verliert: AstraZeneca steigert Umsatz im 3. Quartal und hebt Ausblick für 2024 an (Dow Jones) | |
11.11.24 |
Ausblick: AstraZeneca gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu AstraZeneca PLC (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Amazon | 214,55 | -1,08% | |
AstraZeneca PLC (spons. ADRs) | 62,00 | 0,00% | |
Microsoft Corp. | 417,15 | -1,70% | |
Morgan Stanley | 117,44 | 0,84% | |
Pfizer Inc. | 25,28 | 1,79% |